Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

26 May 2016

Abstract excerpt

Dendritic cells (DCs) are potent antigen-presenting cells (APCs) that play a critical role in the induction of antitumor immunity. Therefore, various strategies have been developed to deliver tumor-associated antigens (TAAs) to DCs as cancer vaccines. The fusion of DCs and whole tumor cells to generate DC-tumor fusion cells (DC-tumor FCs) is an alternative strategy to treat cancer patients. The cell fusion method...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27240347
DOI: 10.3390/ijms17060828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dendritic-Tumor Fusion Cell-Based Cancer VaccinesPMID 27240347Read ↗

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.Semantic proximity Read ↗

Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.Semantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.Semantic proximity Read ↗

Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.Semantic proximity Read ↗

Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Semantic proximity Read ↗

Gene-modified dendritic cell vaccines for cancer.Semantic proximity Read ↗

Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells.Semantic proximity Read ↗

Exploiting tumor-associated dendritic cell heterogeneity for novel cancer therapiesSemantic proximity Read ↗

Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cellsSemantic proximity Read ↗

Rewiring dendritic cell function with CLEC9A and DEC205-based chimeric antigen receptorsSemantic proximity Read ↗

Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.